• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱氨酸-谷氨酸转运体和 CD44 的过表达可预测口腔鳞状细胞癌患者的复发和生存。

Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma.

机构信息

Department of Otolaryngology-Head & Neck Surgery, Keimyung University Dongsan Medical Center, Daegu, South Korea.

Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Head Neck. 2018 Nov;40(11):2340-2346. doi: 10.1002/hed.25331. Epub 2018 Oct 10.

DOI:10.1002/hed.25331
PMID:30303590
Abstract

BACKGROUND

This study analyzed the expression of CD44 and cystine-glutamate transporter SLC7A11 (xCT) in primary oral cavity squamous cell carcinoma (SCC) and the relationships of expression to tumor recurrence and patient survival.

METHODS

Associations between CD44 and xCT expression and clinicopathologic results were analyzed in 231 patients with oral cavity SCC. Cox proportional hazard analyses were used to identify factors associated with recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS).

RESULTS

Overexpression of CD44 and/or xCT was associated with advanced T classification, perineural invasion, and lymphovascular invasion (P < .05 each). High expression of xCT was also associated with nodal metastasis and depth of invasion (P < .01 each). Multivariate analysis indicated that high expression of xCT and both xCT and CD44 were independent predictors of poor RFS, DSS, and OS (P < .05 each).

CONCLUSION

Overexpression of xCT or xCT plus CD44 may predict posttreatment recurrence and survival in patients with oral cavity SCC.

摘要

背景

本研究分析了 CD44 和胱氨酸-谷氨酸转运体 SLC7A11(xCT)在原发性口腔鳞状细胞癌(SCC)中的表达,以及其表达与肿瘤复发和患者生存的关系。

方法

分析了 231 例口腔 SCC 患者中 CD44 和 xCT 表达与临床病理结果的关系。采用 Cox 比例风险分析确定与无复发生存(RFS)、疾病特异性生存(DSS)和总生存(OS)相关的因素。

结果

CD44 和/或 xCT 的过度表达与 T 分类晚期、神经周围侵犯和血管淋巴管侵犯有关(P <.05 各)。xCT 的高表达也与淋巴结转移和浸润深度有关(P <.01 各)。多变量分析表明,xCT 高表达以及 xCT 和 CD44 均是口腔 SCC 患者 RFS、DSS 和 OS 不良的独立预测因素(P <.05 各)。

结论

xCT 或 xCT 加 CD44 的过度表达可能预测口腔 SCC 患者治疗后复发和生存。

相似文献

1
Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma.胱氨酸-谷氨酸转运体和 CD44 的过表达可预测口腔鳞状细胞癌患者的复发和生存。
Head Neck. 2018 Nov;40(11):2340-2346. doi: 10.1002/hed.25331. Epub 2018 Oct 10.
2
Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma.术前评估 CD44 介导的侵袭深度作为早期口腔鳞状细胞癌隐匿性转移的预测指标。
Head Neck. 2019 Apr;41(4):950-958. doi: 10.1002/hed.25532. Epub 2018 Dec 18.
3
Independent Predictors of Prognosis Based on Oral Cavity Squamous Cell Carcinoma Surgical Margins.基于口腔鳞状细胞癌手术切缘的预后独立预测因子。
Otolaryngol Head Neck Surg. 2018 Oct;159(4):675-682. doi: 10.1177/0194599818773070. Epub 2018 May 8.
4
Impact of mandibular invasion on prognosis in oral squamous cell carcinoma four centimeters or less in size.下颌骨侵犯对大小在4厘米及以下的口腔鳞状细胞癌预后的影响。
Laryngoscope. 2017 Apr;127(4):849-854. doi: 10.1002/lary.26211. Epub 2016 Aug 2.
5
Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers.对局部区域复发、从未接受过放疗的口腔癌进行放疗。
Head Neck. 2015 Nov;37(11):1633-41. doi: 10.1002/hed.23806. Epub 2014 Aug 28.
6
SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.SLC7A11,半胱氨酸/谷氨酸转运体的一个组成部分,是喉鳞状细胞癌诊断和预后的一个新的生物标志物。
Oncol Rep. 2017 Nov;38(5):3019-3029. doi: 10.3892/or.2017.5976. Epub 2017 Sep 20.
7
Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.接受手术及术后放疗的Ⅲ/Ⅳ期口腔鳞状细胞癌患者疾病复发的相关危险因素
Anticancer Res. 2016 Feb;36(2):785-92.
8
Relationship between postoperative complications and survival after free flap reconstruction for oral cavity squamous cell carcinoma.口腔鳞状细胞癌游离皮瓣重建术后并发症与生存的关系。
Head Neck. 2014 Jan;36(1):55-9. doi: 10.1002/hed.23266. Epub 2013 Apr 4.
9
Nomogram prediction for survival of patients with oral cavity squamous cell carcinoma.口腔鳞状细胞癌患者生存的列线图预测
Head Neck. 2016 Dec;38(12):1826-1831. doi: 10.1002/hed.24507. Epub 2016 May 26.
10
Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.头颈部皮肤鳞状细胞癌复发及区域淋巴结肿大的相关因素
Otolaryngol Head Neck Surg. 2017 May;156(5):863-869. doi: 10.1177/0194599817697053. Epub 2017 Mar 21.

引用本文的文献

1
Spatial colocalization and molecular crosstalk of myofibroblastic CAFs and tumor cells shape lymph node metastasis in oral squamous cell carcinoma.肌成纤维细胞癌相关成纤维细胞(CAFs)与肿瘤细胞的空间共定位和分子串扰塑造了口腔鳞状细胞癌的淋巴结转移。
PLoS Genet. 2025 Sep 4;21(9):e1011791. doi: 10.1371/journal.pgen.1011791. eCollection 2025 Sep.
2
Immunohistochemistry for Skin Cancers: A Comprehensive Approach to the Diagnosis of Squamous Cell Carcinoma.皮肤癌的免疫组织化学:鳞状细胞癌诊断的综合方法
Cancers (Basel). 2025 May 12;17(10):1629. doi: 10.3390/cancers17101629.
3
Cancer neuroscience in head and neck: interactions, modulation, and therapeutic strategies.
头颈癌神经科学:相互作用、调节及治疗策略
Mol Cancer. 2025 Mar 31;24(1):101. doi: 10.1186/s12943-025-02299-6.
4
Clinicopathological characteristics of invasive stratified mucinous carcinoma of the cervix and the expression and clinical significance of SLC7A11, SLC3A2 and PD-L1.宫颈浸润性分层黏液癌的临床病理特征及SLC7A11、SLC3A2和PD-L1的表达与临床意义
Front Oncol. 2024 Dec 30;14:1492498. doi: 10.3389/fonc.2024.1492498. eCollection 2024.
5
The intricate interplay between ferroptosis and efferocytosis in cancer: unraveling novel insights and therapeutic opportunities.癌症中细胞铁死亡与胞葬作用之间的复杂相互作用:揭示新见解和治疗机会。
Front Oncol. 2024 Oct 31;14:1424218. doi: 10.3389/fonc.2024.1424218. eCollection 2024.
6
xCT as a Predictor for Survival in a Population-Based Cohort of Head and Neck Squamous Cell Carcinoma.xCT 作为头颈鳞状细胞癌人群队列中生存的预测因子。
Cancer Med. 2024 Nov;13(21):e70371. doi: 10.1002/cam4.70371.
7
Unveiling therapeutic avenues targeting xCT in head and neck cancer.揭示头颈部癌中靶向xCT的治疗途径。
Cell Oncol (Dordr). 2024 Dec;47(6):2019-2030. doi: 10.1007/s13402-024-00997-9. Epub 2024 Oct 3.
8
Competing endogenous RNA networks and ferroptosis in cancer: novel therapeutic targets.竞争内源性 RNA 网络与癌症中的铁死亡:新的治疗靶点。
Cell Death Dis. 2024 May 22;15(5):357. doi: 10.1038/s41419-024-06732-4.
9
The prognostic and clinicopathological significance of SLC7A11 in human cancers: a systematic review and meta-analysis.SLC7A11 在人类癌症中的预后和临床病理意义:系统评价和荟萃分析。
PeerJ. 2023 Feb 27;11:e14931. doi: 10.7717/peerj.14931. eCollection 2023.
10
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis.Erk1/2 依赖性头颈部鳞状细胞癌细胞对 Erastin 诱导的铁死亡敏感性。
Cells. 2023 Jan 16;12(2):336. doi: 10.3390/cells12020336.